CD47在CD24上占主导地位,作为癌症中的巨细胞免疫检查点
bioRxiv : the preprint server for biology
|December 9, 2024
概括
CD47是癌症中的重要巨细胞免疫检查点,其性能优于CD24. 针对瘤抗原和巨细胞的新型双特异性抗体显示出癌症免疫治疗的前景,通过引导髓状细胞根除固体瘤.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 巨细胞对于癌症免疫疗法至关重要,但针对瘤激活它们的最佳策略尚不清楚.
- 针对CD47和CD24等巨细胞免疫检查点是一种潜在的治疗方法.
研究的目的:
- 为了评估向CD47和CD24的治疗潜力,两个不同的巨细胞免疫检查点.
- 为增强癌症免疫疗法设计新的双特异性抗体.
主要方法:
- 在体外和体内研究使用针对CD47和CD24的抗体.
- 全基因组的CRISPR选以确定CD24的作用.
- 77种新型双特异抗体的工程和测试.
主要成果:
- 抗CD47和抗CD24抗体在体外诱导了细胞分裂.
- CD24被确定为一个opsonization目标,而不是一个主要的免疫检查点,有效性有限,毒性显著.
- 新的双特异性抗体显示出最大的巨介导细胞毒性和减少与健康血细胞的结合.
结论:
- 与CD24相比,CD47是癌症中占主导地位的巨细胞免疫检查点.
- 针对瘤抗原和巨细胞的工程双特异性抗体是指导骨髓细胞介导瘤根除的有希望的策略.
相关概念视频
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:22T Cell Activation and Clonal Selection
658
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
658